Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Omalizumab Xolair

Omalizumab (Xolair) is an anti-IgE antibody approved for the treatment of allergic asthma not well controlled by oral or inhaled corticosteroids. The dosage is determined by the patient s baseline total serum IgE (international units/mL) and body weight (kg). Doses range from 150 to 375 mg given subcutaneously at either 2- or 4-week intervals. [Pg.932]

Oral 250 mg capsules 500 mg tablets 200 mg powder for suspension 180, 360 mg delayed-release tablets Parenteral 500 mg powder reconstitute for injection Omalizumab (Xolair)... [Pg.1207]

Omalizumab Xolair Asthma (positive skin test or in-vitro reactivity to a perennial aeroallergen) 2003 (not by EMEA)C)... [Pg.88]

Omalizumab Xolair Genentech Anti-IgE IgGl kappa Asthma 2003... [Pg.593]

Omalizumab Xolair (Genentech/Novartis/Tanox Asthma... [Pg.273]

Omalizumab Xolair Genentech, Novartis humanized mAb IgE allergic asthma 2003 IgGl <0.1%... [Pg.1151]

Omalizumab (Xolair) is the first biological drug approved for the treatment of asthma. Omalizumab is a recombinant humanized monoclonal antibody targeted against IgE. IgE bound to omalizumab cannot bind to IgE receptors on mast cells and basophils, thereby preventing the allergic reaction at a very early step in the process. [Pg.514]

Omalizumab Xolair Humanized IgE Allergic asthma Genentech... [Pg.250]

Anti-inflammatory Activities of Omalizumab (Xolair), A Recombinant Humanized Monoclonal Antibody Binding IgE... [Pg.265]

Soler M, Buhl R, Bensch G, Noga O, O Brien J, Champain K, Fox H, Thirlwell J, Rohane R, Gupta N, Fick R, Della Cioppa G. Omalizumab (Xolair , rhuMAb-E25) treatment reduces inhaled corticosteroid use in moderate/severe allergic asthma. Am J Resp Crit Care Med 2001 163 A858. [Pg.468]

See other pages where Omalizumab Xolair is mentioned: [Pg.63]    [Pg.383]    [Pg.56]    [Pg.240]    [Pg.447]    [Pg.55]    [Pg.240]    [Pg.488]    [Pg.114]    [Pg.63]    [Pg.331]    [Pg.468]    [Pg.55]    [Pg.240]    [Pg.795]    [Pg.1979]    [Pg.353]    [Pg.7]    [Pg.267]    [Pg.269]    [Pg.271]    [Pg.273]    [Pg.275]    [Pg.277]    [Pg.279]    [Pg.281]    [Pg.563]   
See also in sourсe #XX -- [ Pg.383 ]



SEARCH



Anti-inflammatory Activities of Omalizumab (Xolair), a Recombinant Humanized Monoclonal Antibody Binding IgE

Omalizumab

© 2024 chempedia.info